1. Home
  2. UFG vs SERA Comparison

UFG vs SERA Comparison

Compare UFG & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UFG
  • SERA
  • Stock Information
  • Founded
  • UFG 2021
  • SERA 2008
  • Country
  • UFG Singapore
  • SERA United States
  • Employees
  • UFG N/A
  • SERA N/A
  • Industry
  • UFG Oil Refining/Marketing
  • SERA Precision Instruments
  • Sector
  • UFG Energy
  • SERA Health Care
  • Exchange
  • UFG Nasdaq
  • SERA Nasdaq
  • Market Cap
  • UFG 136.4M
  • SERA 142.9M
  • IPO Year
  • UFG 2025
  • SERA 2021
  • Fundamental
  • Price
  • UFG $5.52
  • SERA $3.54
  • Analyst Decision
  • UFG
  • SERA
  • Analyst Count
  • UFG 0
  • SERA 0
  • Target Price
  • UFG N/A
  • SERA N/A
  • AVG Volume (30 Days)
  • UFG 385.7K
  • SERA 97.9K
  • Earning Date
  • UFG 01-01-0001
  • SERA 03-19-2025
  • Dividend Yield
  • UFG N/A
  • SERA N/A
  • EPS Growth
  • UFG N/A
  • SERA N/A
  • EPS
  • UFG 0.02
  • SERA N/A
  • Revenue
  • UFG $130,669,391.00
  • SERA $77,000.00
  • Revenue This Year
  • UFG N/A
  • SERA $4,536.36
  • Revenue Next Year
  • UFG N/A
  • SERA $411.43
  • P/E Ratio
  • UFG $289.31
  • SERA N/A
  • Revenue Growth
  • UFG 129.69
  • SERA N/A
  • 52 Week Low
  • UFG $3.50
  • SERA $3.52
  • 52 Week High
  • UFG $5.73
  • SERA $12.36
  • Technical
  • Relative Strength Index (RSI)
  • UFG N/A
  • SERA 32.61
  • Support Level
  • UFG N/A
  • SERA $3.77
  • Resistance Level
  • UFG N/A
  • SERA $4.20
  • Average True Range (ATR)
  • UFG 0.00
  • SERA 0.24
  • MACD
  • UFG 0.00
  • SERA 0.02
  • Stochastic Oscillator
  • UFG 0.00
  • SERA 2.45

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.

Share on Social Networks: